Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
3. Overactive bladder treatment: Advanced Uro-solutions bought by Medtronic
Medtronic has wrapped up yet another acquisition, buying Advanced Uro-Solutions, a Tennessee company whose neurostimulation products focus on treating patients with overactive bladder, for an undisclosed amount of money.
The deal is relatively small, but crucial, because it adds another variation of neurostimulation technology to the device giant’s portfolio. Read more
2. AdvaMed official: India’s medtech market could be $30 billion in a decade
While the medical device industry in India is worth about $4 billion today, that number could climb to $30 billion in a decade with regulations and government policies that spur investment and growth.
The Economic Times quotes AdvaMed India Working Group Chair Sanjay Banerji as making that prediction, assuming industry-friendly regulatory and government policies can be put in place. Read more
1. Report: C.R. Bard to settle W. Va. pelvic-mesh case
C.R. Bard is reportedly close to settling a suit filed in West Virginia federal court by a woman who claimed she was injured by the company’s pelvic-mesh device, Avaulta Plus.
According to Law360, recent court papers indicate the two parties have a settlement pending in the case, which has been removed from the active docket. A trial had been slated to begin in February. Read more
